版本:
中国

BRIEF-CTi biopharma granted 180 day extension by NASDAQ to regain compliance

Sept 22 CTi Biopharma Corp :

* CTi Biopharma granted 180 day extension by NASDAQ to regain compliance with minimum bid price rule

* On September 20, 2016, NASDAQ listing qualifications granted co until March 20, 2017, regain compliance with minimum bid price rule Source text for Eikon:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐